Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$86.58M$86.58Mderived+32.0% vs Q4 2023 Net Income$87.70M$87.70MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$84,379,000N/M Operating Cash Flowderived$21,889,000N/M Margins · derivedOperating margin97.5%+284.5 pt vs Q4 2023
Net margin101.3%+281.4 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 28, 2025 · 59 d after period end